Join
Live feed
·
PRReleasevia Quantisnow
TherapeuticsMD Inc. logo

TherapeuticsMD Completes Transaction to License Its Products to Mayne Pharma

ByQuantisnow·Wall Street's wire, on your screen.
TXMD· TherapeuticsMD Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TXMD (TherapeuticsMD Inc.) and more on Quantisnow.